The GET SET Study is a research study for women who take medicines to help keep breast cancer from coming back. These medicines are called endocrine therapies and include Tamoxifen and Arimidex. The study will test different kinds of extra support programs, such as daily text message reminders and telephone counseling sessions, for women taking these medicines. We want to learn which support programs help women take their medicine as it is prescribed by their doctor.

The purpose of this study is to assess how the use of community health-workers for human papillomavirus (HPV) testing influences the number of women living with HIV who get screened for cervical cancer.

The purpose of this study is to evaluate a new test being developed by Tempus for patients with Non-Small Cell Lung Cancer (NSCLC). The goal of this new test is to predict the likelihood of a patient's cancer coming back after treatment, and to further explore changes in patient's tumors throughout treatment to see how they respond.

To evaluate the safety and effectiveness of the GPX® Embolic Device when used as indicated for embolization procedures, procedures to stop blood flow to certain tumors.

We are conducting this study to better understand the relationship between access to care, financial stress and health related quality of life among cancer patients in NC who live in rural areas. We will be interviewing 30 rural cancer patients to learn about their cancer experience and we will be reviewing previously completed surveys about their distress and coping behaviors.

You are being asked to participate in this study because you have an appointment at UNC Urology, and you have been diagnosed with prostate cancer. The purpose of this research study is to learn how either cryosurgery or prostatectomy procedures change the inflammatory response within the body. To do this, we will draw blood and analyze it for signs of inflammation before and after your standard of care procedure.

We are surveying families of pediatric hematology/oncology patients to find out their interest in and use of integrative and complementary health practices.

The main purpose of this clinical research study is to assess the safety, tolerability, efficacy (the ability of the study drug to produce the desired anti cancer effect), PK] and PD of GHF009X2101 the study drug in patients with relapsed or refractory hematologic malignancies including AML, CLL, SLL or other lymphomas [including other leukemia].

The DNA that we can test from a nasal swab, can help us determine a patient's lung cancer risk. For patients with new lung nodules found on CT scans, we are offering this nasal swab test and collecting data on how physicians use test results to help assess risk and determine treatment strategies.

To see if women who had breast cancer at ages 18-40 were able to successfully lactate and breastfeed after lumpectomy and radiation treatment afterwards.